Head growth in cystic fibrosis following early diagnosis by neonatal screening

Archives of Disease in Childhood

Volumn 75, Issue 3, 1996, Pages 191-193

  Ghosal, S ^a   Taylor, C J ^a,b   Pickering, M ^a   McGaw, J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

AuxoIogy; Cystic fibrosis; Neonatal screening

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BODY WEIGHT; CYSTIC FIBROSIS; GROWTH RATE; HEAD CIRCUMFERENCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN SCREENING; PRESCHOOL CHILD; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 0029832665     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.3.191     Document Type: Article

References (20)

1. Ghosal S, Taylor CJ, Pickering M, McGaw J, Beckles-Willson N, Wales JKH. Disproportionate head growth patterns in cystic fibrosis. Arch Dis Child 1995;72:150-2.
2. Wilson JM. Principles of screening for disease. Proc R Soc Med 1971;64:1255-6.
3. Holtzmann NN. Newborn screening for hereditary metabolic disorders: desirable characteristics, experience and issues. In: Kabach M, ed. Genetic issues in pediatrics, perinatology and obstetrical practice. Chicago: Yearbook Publishers, 1981:455-70.
4. Ranieri E, Ryall RG, Morris CP, et al. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. BMJ 1991;302:1237-40.
5. Wilcken B, Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet 1985; ii:1319-21.
6. Chatfield S, Owen G, Ryley HC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 1991;66:29-33.
7. Department of Health. Dietary reference values for food energy and nutrients in the United Kingdom. London: HMSO, 1991.
8. Tanner JM, Whitehouse RH, Marshall WA, Healy MJR, Goldstein H. Assessment of skeletal maturity and prediction of adult height (TW2 method). London: Academic Press, 1975.
9. Bronstein MN, Sokol RJ, Abman SH, et al. Pancreatic insufficiency, growth and nutrition in infants identified by neonatal screening as having cystic fibrosis. J Pediatr 1992;120: 533-540.
10. Karlberg J, Kjellmar I, Kristiansson B. Linear growth in children with cystic fibrosis. Acta Paediatr Scand 1991;80: 508-14.
11. Winick M, Rosso P. Head circumference and cellular growth of the brain in normal and marasmic children. J Pediatr 1969;80:508-14.
12. Graham G. Effect of infantile malnutrition on growth. Fed Proc 1967;26:139-43.
13. Levitsky DA, Strupp BJ. Malnutrition and the brain: changing concepts, changing concerns. J Nutr 1995;125(suppl 8):2212-20S.
14. Lee JA, Dickinson LS, Kilgore HS, Warren RH, Elders MJ. Somatomedin activity in cystic fibrosis and reserpinized rats: possible explanation for growth retardation. Ann Clin Lab Sci 1980;10:227-33.
15. Rosenfeld RG, Landon C, Lewiston N, Nagashima R, Hintz RL. Demonstration of normal plasma somatomedin concentrations in cystic fibrosis. J Pediatr 1981;99:251-4.
16. Mulberg AE, Resta LP, Wiedner EB Altschuler SM, Jefferson DM, Broussard DL. Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain. J Clin Invest 1995;96:646-52.
17. Blatter DD, Bigler ED, Gale SD, et al. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. Am J Neuroradiol 1995;16:241-51.
18. Ballesteros MC, Hansen PE, Soila K. MR imaging of the developing human brain. Part 2. Postnatal development. Radiographics 1993;13:611-22.
19. Dorin JR, Dickinson P, Alton EW, et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 1992; 358:211-5.
20. Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science 1992;257:1083-8.